Sanofi bets big on AI again, paying $100M to start drug R&D pact with Exscientia January 7, 2022 Auto Bot AI drug discovery, Artificial Intelligence, BioPharma, biopharma nl, cancer, deals, exscientia, France, immunology, Oxford, Paris, Pharma, Sanofi, United Kingdom 0 Sanofi’s new alliance with artificial intelligence biotech Exscientia spans up to 15 small molecule drugs in cancer and immunology. If drugs from the partnership reach the market, Exscientia could earn as much as $5.2 billion in milestone payments.